Bank of New York Mellon
ONCY

Bank of New York Mellon’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bank of New York Mellon’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,027
Closed -$29K – 4229
2013
Q2 		$29K Buy
+10,027
New +$27.7K ﹤0.01% 4088

Other funds holding ONCY

AIM
Acuity Investment Management Toronto, Ontario, Canada $70.8M AUM 0.92% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

Bank of New York Mellon's ONCY Position: Q3 2013 in Review

Bank of New York Mellon sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2013, closing a stake of 10,027 shares — an estimated $29K sold.

Bank of New York Mellon first reported a position in ONCY in Q2 2013 and held it in 1 quarter. The position peaked at $29K in Q2 2013. 39 funds tracked by Wall St. Rank hold ONCY as of Q3 2013.

  • Bank of New York Mellon reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2013 after selling out during the quarter.
  • Bank of New York Mellon sold 10,027 ONCOLYTICS BIOTECH INC shares in Q3 2013, an estimated $29K.
  • Bank of New York Mellon first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 1 quarter.
  • Bank of New York Mellon's ONCOLYTICS BIOTECH INC position peaked at $29K in Q2 2013.
  • 39 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2013.

Based on Bank of New York Mellon's 13F filing for Q3 2013, filed 13 Nov 2013.